Facebook Twitter YouTube Google Plus

Asbestos and Meso Research | Science Advisory Board | Raffit Hassan, MD

Meet Raffit Hassan, MD - Immediate Past Chairman

Mesothelioma Research Experts: Raffit Hassan, MD

Dr. Hassan, is an Investigator and Chief of the Solid Tumor Immunotherapy Section in the Laboratory of Molecular Biology at the National Cancer Institute. Dr. Hassan is a medical oncologist whose laboratory and clinical research is focused on developing novel therapies for the treatment of mesothelioma. Work done by him and his collaborators has shown that mesothelin, a tumor antigen which was discovered at the NCI, is a useful target for tumor-specific therapy of malignant mesothelioma. His group is presently conducting clinical trials of three different agents targeting mesothelin namely, SS1P an anti-mesothelin immunotoxin, MORAb-009 a chimeric anti-mesothelin monoclonal antibody and CRS-207 a mesothelin tumor vaccine.

Back to Science Advisory Board